Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8411-8420 Newer>

Chemistry World September 11, 2012 Maria Burke	Orphan drugs set for 'tremendous growth' A new report by Thomson Reuters offers clear confirmation that developing drugs for rare, or orphan, diseases is economically attractive, despite the smaller patient pool.
Chemistry World September 10, 2012	Chinese Drug Makers Accused of Using 'Gutter Oil' Several Chinese drug companies stand accused of manufacturing an antibiotic intermediate using contaminated 'gutter oil', instead of more expensive soybean oil.
Chemistry World September 6, 2012 Andrew Turley	Merck KGaA to cut 1100 German jobs Merck KGaA has announced plans to cut 1100 jobs in Germany -- a 10% reduction in its German workforce. The job cuts will be made by the end of 2015, 'in a socially acceptable manner.
Chemistry World September 6, 2012 Andrew Turley	Valeant buys $2.6bn skincare firm Canadian pharma company Valeant is to buy US firm Medicis in a $2.6 billion deal. Medicis produces prescription dermatology products as well as over the counter products.
HBS Working Knowledge September 5, 2012	Will Business Management Save US Health Care? Judging from the recent writing of physicians like Atul Gawande, US health care may be in the process of discovering management.
Chemistry World September 4, 2012 Sarah Houlton	Drug Maker Apologizes for Thalidomide Tragedy The manufacturer of thalidomide, German company Grunenthal, has finally issued an apology for the effects the drug had on babies, half a century after the event.
Chemistry World August 28, 2012 Andrew Turley	Myelofibrosis drug approved in EU Jakavi (ruxolitinib) tablets have been approved in the EU for the treatment of myelofibrosis, a rare disease affecting the bone marrow.
Chemistry World August 28, 2012 Andrea Sella	Luer's syringe The Wulfing-Luers family left an indelible mark on the sciences with their syringes. The Luer-lok and Luer-slip are universal and the original 6 taper now has its own ISO, DIN and EN standards.
Chemistry World August 24, 2012 Andrew Turley	Merck KGaA buys cell culture company Merck KGaA has struck a deal to buy German company Biochrom, which makes cell culture media and buffer solutions, for an undisclosed price.
Chemistry World August 24, 2012 Andrew Turley	Alzheimer's drug flops in Phase III A previously promising drug candidate for the treatment of Alzheimer's disease, solanezumab from Eli Lilly, has delivered disappointing results in Phase III trials.
<Older 8411-8420 Newer> Return to current articles.